Sepsis - the #1 complication causing death in COVID patients The pandemic is driving a growing unmet need when it comes to addressing the dramatic impact of sepsis deaths, which is still the #1 complication causing death among COVID-19 patients. Across overall statistics, sepsis kills over 11M people per year with 1:5 afflicted with sepsis dying to it.
There’s a seriously massive opportunity with ASEP Medical Holdings operating across their subsidiaries ABT Innovations and Sepset Biosciences who are developing and testing a treatment for biofilms which account for 65% of all bacterial infections causing Sepsis in addition to a rapid test to accurately identify severe sepsis, saving many more lives.
Definitely a very interesting and promising play, currently trading at .73, one to watch for sure as many early investors are still holding and in no rush to sell. Learn more about them in the video introducing new IPOs: https://youtu.be/xwr1rxwuWSk?t=763.